←Back to Expert Scholars
Translational Medicine / 转化医学Arginine Deiminase Therapeutics
Douglas Lakin
PhD
🏢University of Birmingham🌐UK
Associate Professor of Biochemistry
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Douglas Lakin studies arginine deiminase therapeutics such as ADI-PEG20 in combination regimens for mesothelioma and soft tissue sarcoma. His work links ASS1 status with response and explores resistance mechanisms. He collaborates on UK clinical trials in arginine deprivation.
Share:
🧪Research Fields 研究领域
arginine deiminase
ADI-PEG20
mesothelioma
sarcoma
cancer metabolism
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Douglas Lakin 的研究动态
Follow Douglas Lakin's research updates
留下邮箱，当我们发布与 Douglas Lakin（University of Birmingham）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment